Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS) - Che, Xinzhen; Zhu, Yong (Frontiers in Pharmacology, 2025)